Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
      • The Challenge Initiative Platform
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Alerts
  • Visit GHSP on Facebook
  • Follow GHSP on Twitter
  • RSS
  • Find GHSP on LinkedIn
COMMENTARY
Open Access

Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls

Ilene S. Speizer, Jason Bremner and Shiza Farid FP2020 Performance, Monitoring, and Evidence Working Group
Global Health: Science and Practice February 2022, 10(1):e2100450; https://doi.org/10.9745/GHSP-D-21-00450
Ilene S. Speizer
aDepartment of Maternal and Child Health and Carolina Population Center, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: speizer@email.unc.edu
Jason Bremner
bFP2030, Washington DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiza Farid
bFP2030, Washington DC, USA.
cAvenir Health, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PreviousNext
  • Article
  • Info & Metrics
  • Comments
  • PDF
Loading
Submit a Comment to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • RE: The importance of including manufacturers in making language and measurement of contraceptive need indicators more meaningful for measuring fertility intentions
    Denise L Harrison
    Published on: 25 May 2022
  • Published on: (25 May 2022)
    Page navigation anchor for RE: The importance of including manufacturers in making language and measurement of contraceptive need indicators more meaningful for measuring fertility intentions
    RE: The importance of including manufacturers in making language and measurement of contraceptive need indicators more meaningful for measuring fertility intentions
    • Denise L Harrison, Senior Market Development Advisor, Camris - USAID Contractor

    In GHSP’s February 2022 commentary “Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls,” the authors issue a call to action from the Performance, Monitoring and Evidence Working Group (PME-WG) to the broader Family Planning (FP) community (e.g., survey researchers, governments, donors, policy advocates, and program managers) to work toward (1) developing better metrics to improve analysis, policy, and program planning at the country level and (2) testing novel metrics and sharing findings widely. A noticeable omission from the targeted group of stakeholders is manufacturers. These manufacturers include big and small pharmaceutical companies, biotech companies, app developers, companies that currently manufacture contraceptives and devices as well as those who may be interested in contraceptive pharmaceutical and device manufacturing in the future.

    Historically, manufacturers have played an important role in shaping and measuring women’s fertility intentions, starting most notably with the advent of oral contraceptive pill Since the introduction of the pill, manufacturers have been responding to women’s reproductive and contraceptive needs by developing different methods including injectable contraceptives, implants, patches and vaginal rings, many of which were supported by USAID and non-governmental organizations (NGO) research.

    Increasingly, manufacturers are p...

    Show More

    In GHSP’s February 2022 commentary “Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls,” the authors issue a call to action from the Performance, Monitoring and Evidence Working Group (PME-WG) to the broader Family Planning (FP) community (e.g., survey researchers, governments, donors, policy advocates, and program managers) to work toward (1) developing better metrics to improve analysis, policy, and program planning at the country level and (2) testing novel metrics and sharing findings widely. A noticeable omission from the targeted group of stakeholders is manufacturers. These manufacturers include big and small pharmaceutical companies, biotech companies, app developers, companies that currently manufacture contraceptives and devices as well as those who may be interested in contraceptive pharmaceutical and device manufacturing in the future.

    Historically, manufacturers have played an important role in shaping and measuring women’s fertility intentions, starting most notably with the advent of oral contraceptive pill Since the introduction of the pill, manufacturers have been responding to women’s reproductive and contraceptive needs by developing different methods including injectable contraceptives, implants, patches and vaginal rings, many of which were supported by USAID and non-governmental organizations (NGO) research.

    Increasingly, manufacturers are playing a critical role – and sometimes the leading role - in focusing more on clients vs providers, as witnessed in their direct-to-consumer outreach and education as well in drug development. Such an effort requires contraceptive manufacturers and developers to rethink language directed at clients and continuous measurement of contraceptive needs for older as well as new methods. For example, companies now using social media platforms to reach and interact with users are communicating more around users’ self-identified needs and preferences. For newer drugs, companies are changing in part due to payers like insurance companies and pharmacy benefit companies paying for performance . This is also due to digital health and IT disruptions to healthcare making healthcare companies more focused on users and their needs. For example, using fertility biomarkers to avoid pregnancy has existed for decades. Somewhat recently, app developers introduced Fertility Awareness Method IT applications (apps) to address women’s desire for both easy-to-use, non-hormonal contraceptive methods as well as for less expensive and less invasive fertility aids. This development has disrupted both the natural contraceptive movement and the fertility industry. , , The proliferation of FAM apps in both HICs and LMICs is an illustration of IT developers finding ways to address women’s fertility intentions.

    Developing better metrics to improve analysis is in the manufacturers’ interest to better understand current and future use to forecast profit as accurately as possible. As innovations change to meet women’s reproductive health needs, manufacturers must adopt different metrics. Industry can use existing indicators to measure success but will need new/adapted indicators to capture client needs and desires, some of which - but not all - will correlate with the needs of government and civil society.

    USAID has a long history of partnering with pharmaceutical companies to develop new contraceptive technology and products. Nonetheless, many in the FP community remain suspicious of manufacturers.
    Although manufacturers and the FP community have different incentives, they have some common interests. For example, cost is a consideration for everyone. The cost of family planning programs and commodities is an important concern among national governments. A 2012 volume guarantee by donors, including USAID, then DFID, UNECE (Norway) and the Bill and Melinda Gates Foundation (BMGF) to procure implant contraceptives permitted manufacturers to reduce their price and increase implant distribution by more than 50%, saving donors hundreds of millions of dollars over several years.

    Client satisfaction is another common area. Both parties want more clients to stay on their contraceptive regimen as long as they want to be on them. The FP community can work with industry to contribute to creating appropriate indicators to measure and establish appropriate measurements for programming. To be profitable, companies need highly functioning family planning programs that serve the needs of clients. There is a lot of benefit for the FP community to view contraceptive manufacturers as partners in helping them to achieve effective FP programming. Collaboration can improve the process to help both parties get the outcome they want to achieve. With the advent of FP2030 there is an opportunity to include manufacturers as partners.

    Let’s include healthcare manufacturers in the call to action to make refinements to current language and measurement of contraceptive need indicators that better capture self-identified needs and preferences and develop new measures and methods that capture the perspectives of users, potential users, and non-users.

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 10 (1)
Global Health: Science and Practice
Vol. 10, No. 1
February 28, 2022
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls
Ilene S. Speizer, Jason Bremner, Shiza Farid
Global Health: Science and Practice Feb 2022, 10 (1) e2100450; DOI: 10.9745/GHSP-D-21-00450

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls
Ilene S. Speizer, Jason Bremner, Shiza Farid
Global Health: Science and Practice Feb 2022, 10 (1) e2100450; DOI: 10.9745/GHSP-D-21-00450
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • HISTORICAL PERSPECTIVE OF NEED-BASED MEASURES
    • CHALLENGES WITH LANGUAGE AND USE OF NEED-BASED MEASURES
    • PROPOSED WAYS FORWARD
    • Acknowledgments
    • Funding statement
    • Author contributions
    • Competing interests
    • Footnotes
    • Notes
    • REFERENCES
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Case for Using a Behavior Change Model to Design Interventions to Promote Respectful Maternal Care
  • Does the Current Global Health Agenda Lack Vision?
  • Networks of Care: An Approach to Improving Maternal and Newborn Health
Show more COMMENTARY

Similar Articles

Subjects

  • Health Topics
    • Family Planning and Reproductive Health
US AIDJohns Hopkins Center for Communication ProgramsUniversity of Alberta

Follow Us On

  • Twitter
  • Facebook
  • LinkedIn
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers
  • GH Journals Database

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2023 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire